Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

The recurrence of prolactinoma after withdrawal of dopamine agonist: A systematic review and meta-analysis

BMC Endocrine Disorders | Nov 22, 2021 Clinical Pharmacology

Ranitidine and risk of bladder and kidney cancer: A population-based cohort study

Cancer Epidemiology, Biomarkers & Prevention | Nov 22, 2021 Clinical Pharmacology

Prevalence of impaired kidney function in patients with long‐term lithium‐treatment: A systematic review and meta‐analysis

Bipolar Disorders | Nov 21, 2021 Clinical Pharmacology

Tocilizumab found effective in Behcet’s syndrome with refractory arterial lesions

Rheumatology | Nov 21, 2021 Clinical Pharmacology

Consistent safety profile with up to five years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis

Journal of the American Academy of Dermatology | Nov 21, 2021 Clinical Pharmacology

Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open‐label extension phase

Journal of the European Academy of Dermatology and Venereology | Nov 21, 2021 Clinical Pharmacology

Milvexian for the prevention of venous thromboembolism

New England Journal of Medicine | Nov 20, 2021 Clinical Pharmacology

Once-weekly cagrilintide for weight management in people with overweight and obesity: A multicenter, randomized, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

The Lancet | Nov 20, 2021 Clinical Pharmacology

Association of polypharmacy with kidney disease progression in adults with CKD

Clinical Journal of the American Society of Nephrology | Nov 20, 2021 Clinical Pharmacology

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer

The Breast | Nov 20, 2021 Clinical Pharmacology

« Prev 1 … 19 20 21 22 23 … 338 Next »

The recurrence of prolactinoma after withdrawal of dopamine agonist: A systematic review and meta-analysis

Ranitidine and risk of bladder and kidney cancer: A population-based cohort study

Prevalence of impaired kidney function in patients with long‐term lithium‐treatment: A systematic review and meta‐analysis

Tocilizumab found effective in Behcet’s syndrome with refractory arterial lesions

Consistent safety profile with up to five years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis

Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open‐label extension phase

Milvexian for the prevention of venous thromboembolism

Once-weekly cagrilintide for weight management in people with overweight and obesity: A multicenter, randomized, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

Association of polypharmacy with kidney disease progression in adults with CKD

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer

Alternative Therapies and Infection Management

Age Related Macular Degeneration

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Recent Advances in Storage Media for Avulsed Tooth

MIP: Nutrition and Pharmacology: Interactions, Side Effects, and Patient Education

The recurrence of prolactinoma after withdrawal of dopamine agonist: A systematic review and meta-analysis

Ranitidine and risk of bladder and kidney cancer: A population-based cohort study

Prevalence of impaired kidney function in patients with long‐term lithium‐treatment: A systematic review and meta‐analysis

Tocilizumab found effective in Behcet’s syndrome with refractory arterial lesions

Consistent safety profile with up to five years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis

Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: Results of a phase 2 randomized controlled trial with an open‐label extension phase

Milvexian for the prevention of venous thromboembolism

Once-weekly cagrilintide for weight management in people with overweight and obesity: A multicenter, randomized, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

Association of polypharmacy with kidney disease progression in adults with CKD

Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer

Alternative Therapies and Infection Management

Age Related Macular Degeneration

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Recent Advances in Storage Media for Avulsed Tooth

MIP: Nutrition and Pharmacology: Interactions, Side Effects, and Patient Education

Select Specialty

Select Topic